Group One Trading’s TRIUS THERAPEUTICS INC COM STK (DE) TSRX Stock Holding History

Group One Trading’s Portfolio TSRX Stock Details TSRX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2013 Q3	–	Sell	-161,200	Closed	-$1.31M	–	6069
2013 Q2	$1.31M	Buy	+161,200	New	+$1.19M	0.03%	648

Other funds holding TSRX

PAM

Panagora Asset Management Boston, Massachusetts $26.7B AUM 36.4% 1-Year Est. Return

LTFS

Ladenburg Thalmann Financial Services Miami, Florida $15.9B AUM 25.16% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return

FCH

Freestone Capital Holdings Seattle, Washington $3.3B AUM 21.14% 1-Year Est. Return

Amici Capital New York $257M AUM 4.88% 1-Year Est. Return

FWM

Focused Wealth Management Newburgh, New York $964M AUM 18.71% 1-Year Est. Return

Manulife (Manufacturers Life Insurance) Canada, Ontario, Canada $116B AUM 26.37% 1-Year Est. Return

Group One Trading's TSRX Position: Q3 2013 in Review

Group One Trading sold out of TRIUS THERAPEUTICS INC COM STK (DE) (TSRX) in Q3 2013, closing a stake of 108,316 shares — an estimated $880K sold.

Group One Trading first reported a position in TSRX in Q2 2013 and held it in 1 quarter. The position peaked at $880K in Q2 2013. 7 funds tracked by Wall St. Rank hold TSRX as of Q3 2013.

Group One Trading reported no remaining TRIUS THERAPEUTICS INC COM STK (DE) position as of Q3 2013 after selling out during the quarter.
Group One Trading sold 108,316 TRIUS THERAPEUTICS INC COM STK (DE) shares in Q3 2013, an estimated $880K.
Group One Trading first reported a position in TRIUS THERAPEUTICS INC COM STK (DE) in Q2 2013 and held it in 1 quarter.
Group One Trading's TRIUS THERAPEUTICS INC COM STK (DE) position peaked at $880K in Q2 2013.
7 funds tracked by Wall St. Rank held TRIUS THERAPEUTICS INC COM STK (DE) as of Q3 2013.

Based on Group One Trading's 13F filing for Q3 2013, filed 15 Nov 2013.